melatonin has been researched along with moclobemide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| de Andrés, L; Estrada Valencia, M; Herrera-Arozamena, C; Laurini, E; Morales-García, JA; Pérez, C; Pérez-Castillo, A; Pricl, S; Ramos, E; Rodríguez-Franco, MI; Romero, A; Viña, D; Yáñez, M | 1 |
| Cuadrado, A; Duarte, P; Estrada-Valencia, M; Fernández-Ginés, R; Franco-Gonzalez, JF; Gago, F; García-Yagüe, ÁJ; Herrera-Arozamena, C; Lagartera, L; León, R; López, MG; Michalska, P; Mills, A; Morales-García, JA; Pérez, C; Pérez-Castillo, A; Rodríguez-Franco, MI | 1 |
| Duarte, P; Estrada-Valencia, M; Fernández-Mendívil, C; Herrera-Arozamena, C; León, R; Lombardía, J; López, MG; López-Caballero, P; Michalska, P; Morales-García, JA; Pérez, C; Pérez-Castillo, A; Rodríguez-Franco, MI; Sastre, ED; Senar, S | 1 |
| Oxenkrug, GF; Requintina, PJ; Yuwiler, A | 1 |
| Koulu, M; Scheinin, M; Vakkuri, O; Vuorinen, J; Zimmer, RH | 1 |
| McIntyre, IM; Oxenkrug, GF; Requintina, PJ; White, K | 1 |
| Ahmed, SK; Kin, NM; Nair, NP; West, TE | 1 |
| Oxenkrug, GF; Requintina, PJ; White, K; Yuwiler, A | 1 |
| Eli, R; Fasciano, J | 1 |
| Eli, R; Fasciano, JA | 1 |
1 review(s) available for melatonin and moclobemide
| Article | Year |
|---|---|
Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients.
Topics: Aged; Antidepressive Agents, Tricyclic; Benzamides; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Melatonin; Moclobemide; Monoamine Oxidase Inhibitors; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Testosterone; Tyramine | 1995 |
1 trial(s) available for melatonin and moclobemide
| Article | Year |
|---|---|
Moclobemide, an inhibitor of MAO-A, does not increase daytime plasma melatonin levels in normal humans.
Topics: Adult; Benzamides; Double-Blind Method; Humans; Kinetics; Male; Melatonin; Moclobemide; Monoamine Oxidase Inhibitors; Random Allocation; Reference Values | 1990 |
9 other study(ies) available for melatonin and moclobemide
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cell Line; Cholinesterase Inhibitors; Donepezil; Enzyme Inhibitors; Flavonoids; Humans; Indans; Lipoxygenase Inhibitors; Male; Mice, Inbred BALB C; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurogenesis; Neuroprotective Agents; Piperidines; Receptors, sigma; Sigma-1 Receptor | 2018 |
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties.
Topics: Animals; Antioxidants; Cell Line, Tumor; CHO Cells; Cricetulus; Humans; Indoles; Kelch-Like ECH-Associated Protein 1; Ligands; Lipoxygenase Inhibitors; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Monoamine Oxidase Inhibitors; Naphthalenes; Neurogenesis; NF-E2-Related Factor 2; Oxadiazoles; Protein Binding; Quinone Reductases; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2 | 2020 |
Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades.
Topics: Antioxidants; Ligands; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Oxidative Stress; Resveratrol | 2022 |
Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
Topics: Acetyltransferases; Animals; Benzamides; Chromatography, High Pressure Liquid; In Vitro Techniques; Kinetics; Male; Melatonin; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pineal Gland; Rats; Rats, Inbred F344; Spectrometry, Fluorescence | 1990 |
Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
Topics: Animals; Benzamides; Clorgyline; Female; Hydroxyindoleacetic Acid; Melatonin; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pineal Gland; Rats; Rats, Inbred F344; Serotonin; Time Factors | 1994 |
Chronopharmacological study of moclobemide effect on the rat pineal melatonin biosynthesis.
Topics: Animals; Benzamides; Circadian Rhythm; Female; Melatonin; Moclobemide; Monoamine Oxidase Inhibitors; Pineal Gland; Rats; Rats, Inbred F344; Serotonin; Time Factors | 1994 |
A chronopharmacological diagnostic test and treatment for bipolar disorder and depression: nitric oxide release during sleep causes it to become depressogenic in a subset of patients.
Topics: Age Factors; Bipolar Disorder; Brain; Humans; Melatonin; Moclobemide; Nitric Oxide; Polymorphism, Genetic; Regional Blood Flow; Serotonin; Sleep; Time Factors | 2006 |
A chronopharmacological preventive treatment for sleep-related migraine headaches and chronic morning headaches: Nitric oxide supersensitivity can cause sleep-related headaches in a subset of patients.
Topics: Antioxidants; Headache Disorders; Humans; Hydrocortisone; Melatonin; Migraine Disorders; Moclobemide; Monoamine Oxidase Inhibitors; Nitric Oxide; Sleep; Sleep Wake Disorders | 2006 |